Scientists devise genetic model to gauge colon cancer recurrence

11/25/2008 | Yahoo!

U.S. researchers devised a genetic model that they said is 90% accurate in measuring the risk of recurrence in people who have early-stage colon cancer. They also found that the model helped identify anti-inflammatory drugs and other chemotherapy agents that seemed to cause marked changes in tumors. "These findings have important implications for individualizing therapy," the study's lead scientist said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN